Skip to content

13F-HR filed by Ghost Tree Capital, LLC

Ghost Tree Capital, LLC filed this 13F-HR for the quarter ended 2018-03-31, filed 2018-05-15, with 53 holding rows worth $494,288,000.

Accession
0001387131-18-002131
Filed
2018-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2018

A holdings report, 53 entries on the cover page, a total value of $494,288,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $494,288,000 with VALUE read as thousands by filing date, 13F file number 028-16059. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
INCYTE CORP COM45337C102Stock8,333$83,330,000thousands by filing dateput
SPDR SER TR78464A870S&P BIOTECH8,773$35,092,000thousands by filing dateput
IMMUNOMEDICS INC452907108COM1,850,000$27,029,000thousands by filing date
ENDOCYTE INC29269A102COM2,200,000$19,998,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM235,000$17,411,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM1,000,000$16,900,000thousands by filing date
AVEXIS INC05366U100COM135,000$16,683,000thousands by filing date
ROCKET PHARMACEUTICALS INC77313F106COM850,000$15,938,000thousands by filing date
MYLAN NVN59465109SHS EURO350,000$14,410,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM550,000$14,168,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR150,000$12,066,000thousands by filing date
CATALYST BIOSCIENCES INC14888D208COM450,000$11,610,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM750,000$11,280,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM120,000$11,004,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR140,000$9,156,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM950,000$9,082,000thousands by filing date
MOMENTA PHARMACEUTICALS INC60877T100COM500,000$9,075,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM400,000$8,988,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM262,500$8,059,000thousands by filing date
CONCERT PHARMACEUTICALS INC206022105COM350,000$8,015,000thousands by filing date
ADAMAS PHARMACEUTICALS INC00548A106COM325,000$7,766,000thousands by filing date
ALLERGAN PLCG0177J108SHS45,000$7,573,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM150,000$7,371,000thousands by filing date
RETROPHIN INC761299106COM314,367$7,029,000thousands by filing date
KADMON HLDGS INC48283N106COM1,600,000$6,800,000thousands by filing date
AVADEL PHARMACEUTICALS, PLC05337M104COMMON STOCK-FO850,000$6,197,000thousands by filing date
Viewra, Inc92672L107COM900,000$5,787,000thousands by filing date
ARROWHEAD PHARMACEUTICALS IN04280A100COM800,000$5,768,000thousands by filing date
AQUINOX PHARMACEUTICALS INC03842B101COM400,000$5,632,000thousands by filing date
G1 THERAPEUTICS INC3621LQ109COM150,000$5,558,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM200,000$5,412,000thousands by filing date
ObsEva SAH5861P103COM400,000$5,398,000thousands by filing date
NEOS THERAPEUTICS INC64052L106COM600,000$4,980,000thousands by filing date
CHINOOK THERAPEUTICS INC.00739L101Common Stock500,000$4,650,000thousands by filing date
CURRENCYSHARES SWISS FRANC TRU23129V109ETF45,800$4,507,000thousands by filing date
Mersana Therapeutics Inc59045L106Common Stock278,244$4,388,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock300,000$4,260,000thousands by filing date
GLYCOMIMETICS INC38000Q102COM250,000$4,058,000thousands by filing date
LANNETT COMPANY INCORPORATED516012101COM250,000$4,013,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM75,000$3,960,000thousands by filing date
INFINITY PHARMACEUTICALS INC45665G303COM1,750,000$3,675,000thousands by filing date
TESARO INC881569107COM61,900$3,537,000thousands by filing date
SOLID BIOSCIENCES INC COM NEW83422E105Stock385,000$2,888,000thousands by filing date
JOUNCE THERAPEUTICS INC481116101COM125,092$2,796,000thousands by filing date
DBV TECHNOLOGIES S A23306J101ADR100,000$2,307,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM75,100$1,935,000thousands by filing datecall
SAGE THERAPEUTICS INC78667J108COM11,100$1,788,000thousands by filing date
CATALYST PHARMACEUTICALS INC14888U101COM550,000$1,315,000thousands by filing date
KARYOPHARM THERAPEUTICS INC48576U106COM76,786$1,030,000thousands by filing date
NABRIVA THERAPEUTICS PLCG63637105SHS200,000$1,006,000thousands by filing date
ANAPTYSBIO INC032724106COM9,000$937,000thousands by filing date
MOTUS GI HLDGS INC62014P108COM100,000$448,000thousands by filing date
IMMUNOGEN INC45253H101COMMON STOCK7,500$225,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001387131-18-002131this filing2018-05-15acceptance time not in the bulk data set